• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低碳水化合物和低热量饮食可降低代谢功能障碍相关脂肪性肝病(MASLD)患者的肝脏脂肪,并降低其大脑中的谷氨酸和肌醇水平。

Low carbohydrate and low-calorie diets reduce liver fat and lower brain glutamate and myo-inositol levels in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

作者信息

Haley Andreana P, Knight-Scott Jack, Caillaud Marie, Gallagher Isabelle, Park Jessica, Li Yanrong, Wang Tianyu, Tanaka Hirofumi, Browning Jeffrey D

机构信息

Department of Psychology, The University of Texas at Austin, 108 E Dean Keeton, Austin, TX, USA.

Biomedical Imaging Center, The University of Texas at Austin, Austin, TX, USA.

出版信息

Metab Brain Dis. 2025 May 10;40(5):199. doi: 10.1007/s11011-025-01624-8.

DOI:10.1007/s11011-025-01624-8
PMID:40347387
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12065739/
Abstract

In a longitudinal cohort study with intervention (NCT05216796), we utilized multiorgan imaging to determine if metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with elevated cerebral glutamate and myo-inositol and to determine their sensitivity to dietary intervention. Fifty-five adults with self-reported MASLD or high MASLD risk (3 + metabolic risk factors) received liver and brain magnetic resonance spectroscopy scans pre and post two-week low carbohydrate (≤30 g/d) or low-calorie (women ~ 1200 kcal/d; men ~ 1500 kcal/d) diet, both known for their ability to reduce liver fat. Forty-four adults completed the study (36 female, average age 54 years). Thirty out of 44 met clinical criterion for MASLD based on neuroimaging (≥ 5% hepatic triglycerides). Intervention was associated with significant decreases in liver fat fraction (mean difference = 3.101, 95% CI 2.104-4.099, p < 0.0001), glutamate (mean difference = 0.753, 95% CI 0.274-1.233, p = 0.0032) and myo-inositol (mean difference = 0.478, 95% CI 0.180-0.775, p = 0.0027) in patients with confirmed MASLD. Thus, MASLD may be a source of glutamate neurotoxicity and neuroinflammation and diet is an effective strategy for supporting brain as well as liver health.

摘要

在一项有干预措施的纵向队列研究(NCT05216796)中,我们利用多器官成像来确定代谢功能障碍相关脂肪性肝病(MASLD)是否与脑内谷氨酸和肌醇水平升高有关,并确定它们对饮食干预的敏感性。55名自我报告患有MASLD或MASLD高风险(3种及以上代谢风险因素)的成年人在接受为期两周的低碳水化合物(≤30克/天)或低热量(女性约1200千卡/天;男性约1500千卡/天)饮食前后接受了肝脏和脑磁共振波谱扫描,这两种饮食都以能够减少肝脏脂肪而闻名。44名成年人完成了该研究(36名女性,平均年龄54岁)。44名中有30名基于神经成像符合MASLD的临床标准(肝脏甘油三酯≥5%)。干预与确诊为MASLD的患者肝脏脂肪分数显著降低(平均差异=3.101,95%可信区间2.104-4.099,p<0.0001)、谷氨酸(平均差异=0.753,95%可信区间0.274-1.233,p=0.0032)和肌醇(平均差异=0.478,95%可信区间0.180-0.775,p=0.0027)有关。因此,MASLD可能是谷氨酸神经毒性和神经炎症的一个来源,饮食是支持脑和肝脏健康的有效策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c46/12065739/200e4b887fd2/11011_2025_1624_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c46/12065739/2b6accdc87b7/11011_2025_1624_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c46/12065739/3ae33a10ad26/11011_2025_1624_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c46/12065739/200e4b887fd2/11011_2025_1624_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c46/12065739/2b6accdc87b7/11011_2025_1624_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c46/12065739/3ae33a10ad26/11011_2025_1624_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c46/12065739/200e4b887fd2/11011_2025_1624_Fig3_HTML.jpg

相似文献

1
Low carbohydrate and low-calorie diets reduce liver fat and lower brain glutamate and myo-inositol levels in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).低碳水化合物和低热量饮食可降低代谢功能障碍相关脂肪性肝病(MASLD)患者的肝脏脂肪,并降低其大脑中的谷氨酸和肌醇水平。
Metab Brain Dis. 2025 May 10;40(5):199. doi: 10.1007/s11011-025-01624-8.
2
Silymarin for adults with metabolic dysfunction-associated steatotic liver disease.水飞蓟素用于患有代谢功能障碍相关脂肪性肝病的成年人。
Cochrane Database Syst Rev. 2025 Jun 24;6(6):CD015524. doi: 10.1002/14651858.CD015524.pub2.
3
Metabolic dysfunction-associated steatotic liver disease: A story of muscle and mass.代谢功能障碍相关脂肪性肝病:肌肉与体重的故事。
World J Gastroenterol. 2025 May 28;31(20):105346. doi: 10.3748/wjg.v31.i20.105346.
4
Dietary manganese intake is positively associated with metabolic dysfunction-associated steatotic liver disease: a multicohort study.膳食锰摄入量与代谢功能障碍相关脂肪性肝病呈正相关:一项多队列研究。
Eur J Nutr. 2025 May 26;64(5):188. doi: 10.1007/s00394-025-03708-8.
5
Dietary Intake of Major Minerals and Trace Elements in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: Implications for Dietary Intervention.代谢功能障碍相关脂肪性肝病患者主要矿物质和微量元素的膳食摄入:对饮食干预的启示
Adv Ther. 2025 May 29. doi: 10.1007/s12325-025-03238-z.
6
Dietary lipophilic index and odds of metabolic dysfunction-associated steatotic liver disease (MASLD): A population-based study.饮食亲脂性指数与代谢功能障碍相关脂肪性肝病(MASLD)的患病几率:一项基于人群的研究。
Dig Liver Dis. 2025 Jul;57(7):1455-1464. doi: 10.1016/j.dld.2025.04.001. Epub 2025 May 13.
7
The serum uric acid to apolipoprotein A1 ratio is independently correlated with metabolic dysfunction-associated steatotic liver disease in type 2 diabetes mellitus: findings from a single national metabolic management center cohort.血清尿酸与载脂蛋白A1比值与2型糖尿病中代谢功能障碍相关脂肪性肝病独立相关:来自单一国家代谢管理中心队列的研究结果
Front Endocrinol (Lausanne). 2025 Jun 4;16:1619003. doi: 10.3389/fendo.2025.1619003. eCollection 2025.
8
Self-management in patients with metabolic dysfunction-associated steatotic liver disease: influencing factors and impact on readmission.代谢功能障碍相关脂肪性肝病患者的自我管理:影响因素及其对再入院的影响。
J Health Popul Nutr. 2024 Aug 31;43(1):134. doi: 10.1186/s41043-024-00618-z.
9
Weight loss interventions for chronic asthma.慢性哮喘的体重减轻干预措施。
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD009339. doi: 10.1002/14651858.CD009339.pub2.
10
Association of metabolic signatures of air pollution with MASLD: Observational and Mendelian randomization study.空气污染的代谢特征与代谢相关脂肪性肝病的关联:观察性和孟德尔随机化研究
J Hepatol. 2025 Apr;82(4):560-570. doi: 10.1016/j.jhep.2024.09.033. Epub 2024 Sep 28.

本文引用的文献

1
Epidemiology of metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病的流行病学
Clin Mol Hepatol. 2025 Feb;31(Suppl):S32-S50. doi: 10.3350/cmh.2024.0431. Epub 2024 Aug 19.
2
Brain responses to intermittent fasting and the healthy living diet in older adults.老年人对间歇性禁食和健康生活饮食的大脑反应。
Cell Metab. 2024 Aug 6;36(8):1668-1678.e5. doi: 10.1016/j.cmet.2024.05.017. Epub 2024 Jun 19.
3
The Metabolic Impact of Nonalcoholic Fatty Liver Disease on Cognitive Dysfunction: A Comprehensive Clinical and Pathophysiological Review.
非酒精性脂肪肝疾病对认知功能障碍的代谢影响:全面的临床和病理生理学综述。
Int J Mol Sci. 2024 Mar 15;25(6):3337. doi: 10.3390/ijms25063337.
4
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective.代谢功能障碍相关脂肪性肝病和代谢功能障碍相关脂肪性肝炎:患者及医生视角
J Clin Med. 2023 Sep 26;12(19):6216. doi: 10.3390/jcm12196216.
5
Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies.代谢相关脂肪性肝病相关的肝脂肪变性的纵向结局:129 项研究的荟萃分析。
Clin Gastroenterol Hepatol. 2024 Mar;22(3):488-498.e14. doi: 10.1016/j.cgh.2023.09.018. Epub 2023 Sep 28.
6
Evaluation of Brain-Body Health in Individuals With Common Neuropsychiatric Disorders.常见神经精神障碍个体的脑-体健康评估。
JAMA Psychiatry. 2023 Jun 1;80(6):567-576. doi: 10.1001/jamapsychiatry.2023.0791.
7
Acute administration of ketone beta-hydroxybutyrate downregulates 7T proton magnetic resonance spectroscopy-derived levels of anterior and posterior cingulate GABA and glutamate in healthy adults.急性酮体β-羟基丁酸给药下调健康成年人前后扣带回质子磁共振波谱衍生的 GABA 和谷氨酸水平。
Neuropsychopharmacology. 2023 Apr;48(5):797-805. doi: 10.1038/s41386-022-01364-8. Epub 2022 Aug 22.
8
Amyloid-PET Levels in the Precuneus and Posterior Cingulate Cortices Are Associated with Executive Function Scores in Preclinical Alzheimer's Disease Prior to Overt Global Amyloid Positivity.淀粉样蛋白-PET 在前扣带回和后扣带回皮质中的水平与临床前阿尔茨海默病在出现明显全局淀粉样蛋白阳性之前的执行功能评分相关。
J Alzheimers Dis. 2022;88(3):1127-1135. doi: 10.3233/JAD-220294.
9
Is there an association between non-alcoholic fatty liver disease and cognitive function? A systematic review.非酒精性脂肪肝与认知功能之间是否存在关联?系统综述。
BMC Geriatr. 2022 Jan 11;22(1):47. doi: 10.1186/s12877-021-02721-w.
10
Hepatic Manifestations of Urea Cycle Disorders.尿素循环障碍的肝脏表现
Clin Liver Dis (Hoboken). 2021 Sep 1;18(4):198-203. doi: 10.1002/cld.1115. eCollection 2021 Oct.